Search publications


  • Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa Molines A, Barajas A, del Cacho N, Sánchez Fernández B, Pardo M, Baños I, Usall J, Ochoa S, GENIPE Group and PROFEP Group.

    Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.

    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY . 30(9): 1383-1390. Number of citations: 3


  • Huerta-Ramos ME, Ferrer-Quintero M, Gómez-Benito J, González-Higueras F, Cuadras-Palleja D, Del Rey-Mejías AL, Usall J and Ochoa S.

    Translation and validation of Baron Cohen’s face test in a general population from Spain.


  • Sastre-Buades A, Ochoa S, ESTHER LORENTE ROVIRA, Barajas A, Eva Maria Grasa Bello, López-Carrilero R, Luengo A, Isabel Ruiz Delgado, Jordi Cid Colom, González-Higueras F, Sánchez-Alonso S, Baca-García E, Barrigón ML and Spanish Metacognition Study Group.

    Jumping to conclusions and suicidal behavior in depression and psychosis.



  • Alonso-Solís A, Ochoa S, Eva Maria Grasa Bello, Rubinstein K, Caspi A, Farkas K, Unoka Z, Usall J, Huerta-Ramos ME, Isohanni M, Seppälä J, Reixach E, Berdún J, Corripio I and Group MR.

    A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia.



  • Huerta-Ramos ME, Labad J, Cobo JV, Nuñez C, Creus M, García-Parés G, Cuadras-Palleja D, Franco J, Miquel E, Reyes JC, Marcó-García S, RALOPSYCAT Group and Usall J.

    Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial

    European archives of psychiatry and clinical neuroscience . 270(6): 729-737. Number of citations: 6


  • Tost M, Monreal JA, Armario A, Barbero JD, Cobo JV, García-Rizo C, Bioque M, Usall J, Huerta-Ramos ME, Soria V, PNECAT Group and Labad J.

    Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

    CLINICAL DRUG INVESTIGATION . 40(1): 1-14. Number of citations: 13


  • Vila È, Huerta-Ramos ME, Nuñez C, Usall J and Ramos B.

    Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.

    European archives of psychiatry and clinical neuroscience . 269(8): 941-948. Number of citations: 3


  • Marco-Garcia S, Ferrer-Quintero M, Usall J, Ochoa S, del Cacho N and Huerta-Ramos ME.

    Reconocimiento facial de emociones en trastornos neurologicos: una revision narrativa.

    REVISTA DE NEUROLOGIA . 69(5): 207-219. Number of citations: 4


  • Barajas A, MARÍA TRINIDAD PELÁEZ MARTÍNEZ, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.

    Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.

    EARLY INTERVENTION IN PSYCHIATRY . 13(3): 414-424. Number of citations: 2


  • Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.

    Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.

    BMJ Open . 8(7): e021346. Number of citations: 4